TAYLOR MORRISON HOME CORP (TMHC) Stock Fundamental Analysis

NYSE:TMHC • US87724P1066

65.89 USD
+0.08 (+0.12%)
At close: Feb 27, 2026
65.89 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TMHC. TMHC was compared to 60 industry peers in the Household Durables industry. While TMHC has a great profitability rating, there are some minor concerns on its financial health. TMHC has a bad growth rate and is valued cheaply. These ratings could make TMHC a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • TMHC had positive earnings in the past year.
  • TMHC had a positive operating cash flow in the past year.
  • In the past 5 years TMHC has always been profitable.
  • Of the past 5 years TMHC 4 years had a positive operating cash flow.
TMHC Yearly Net Income VS EBIT VS OCF VS FCFTMHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • TMHC's Return On Assets of 8.84% is fine compared to the rest of the industry. TMHC outperforms 78.33% of its industry peers.
  • With a decent Return On Equity value of 13.76%, TMHC is doing good in the industry, outperforming 71.67% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 10.88%, TMHC is doing good in the industry, outperforming 73.33% of the companies in the same industry.
  • TMHC had an Average Return On Invested Capital over the past 3 years of 10.69%. This is in line with the industry average of 9.17%.
  • The last Return On Invested Capital (10.88%) for TMHC is above the 3 year average (10.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.84%
ROE 13.76%
ROIC 10.88%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.98%
ROE(5y)16.31%
ROIC(3y)10.69%
ROIC(5y)11.14%
TMHC Yearly ROA, ROE, ROICTMHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.16%, TMHC belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
  • TMHC's Profit Margin has improved in the last couple of years.
  • TMHC's Operating Margin of 14.53% is amongst the best of the industry. TMHC outperforms 88.33% of its industry peers.
  • In the last couple of years the Operating Margin of TMHC has grown nicely.
  • Looking at the Gross Margin, with a value of 23.91%, TMHC is in line with its industry, outperforming 45.00% of the companies in the same industry.
  • TMHC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.53%
PM (TTM) 10.16%
GM 23.91%
OM growth 3Y-6.84%
OM growth 5Y13.63%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
TMHC Yearly Profit, Operating, Gross MarginsTMHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), TMHC is creating some value.
  • TMHC has less shares outstanding than it did 1 year ago.
  • TMHC has less shares outstanding than it did 5 years ago.
  • TMHC has a worse debt/assets ratio than last year.
TMHC Yearly Shares OutstandingTMHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TMHC Yearly Total Debt VS Total AssetsTMHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • TMHC has an Altman-Z score of 3.88. This indicates that TMHC is financially healthy and has little risk of bankruptcy at the moment.
  • TMHC's Altman-Z score of 3.88 is in line compared to the rest of the industry. TMHC outperforms 60.00% of its industry peers.
  • The Debt to FCF ratio of TMHC is 3.84, which is a good value as it means it would take TMHC, 3.84 years of fcf income to pay off all of its debts.
  • TMHC has a Debt to FCF ratio (3.84) which is comparable to the rest of the industry.
  • TMHC has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.35, TMHC is in line with its industry, outperforming 43.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.84
Altman-Z 3.88
ROIC/WACC1.22
WACC8.89%
TMHC Yearly LT Debt VS Equity VS FCFTMHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 6.43 indicates that TMHC has no problem at all paying its short term obligations.
  • TMHC's Current ratio of 6.43 is fine compared to the rest of the industry. TMHC outperforms 78.33% of its industry peers.
  • A Quick Ratio of 0.58 indicates that TMHC may have some problems paying its short term obligations.
  • TMHC has a worse Quick ratio (0.58) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.43
Quick Ratio 0.58
TMHC Yearly Current Assets VS Current LiabilitesTMHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for TMHC have decreased by -7.51% in the last year.
  • TMHC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.33% yearly.
  • The Revenue has decreased by -0.57% in the past year.
  • TMHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.79% yearly.
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.57% on average over the next years.
  • Based on estimates for the next years, TMHC will show a decrease in Revenue. The Revenue will decrease by -3.50% on average per year.
EPS Next Y-15.13%
EPS Next 2Y2.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.69%
Revenue Next 2Y-3.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMHC Yearly Revenue VS EstimatesTMHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
TMHC Yearly EPS VS EstimatesTMHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.49 indicates a reasonable valuation of TMHC.
  • Compared to the rest of the industry, the Price/Earnings ratio of TMHC indicates a rather cheap valuation: TMHC is cheaper than 90.00% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.10. TMHC is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 10.00 indicates a reasonable valuation of TMHC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TMHC indicates a rather cheap valuation: TMHC is cheaper than 85.00% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of TMHC to the average of the S&P500 Index (28.06), we can say TMHC is valued rather cheaply.
Industry RankSector Rank
PE 8.49
Fwd PE 10
TMHC Price Earnings VS Forward Price EarningsTMHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TMHC is valued a bit cheaper than 75.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, TMHC is valued cheaper than 81.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.3
EV/EBITDA 6.57
TMHC Per share dataTMHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The excellent profitability rating of TMHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.36
EPS Next 2Y2.57%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for TMHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TAYLOR MORRISON HOME CORP

NYSE:TMHC (2/27/2026, 8:04:00 PM)

After market: 65.89 0 (0%)

65.89

+0.08 (+0.12%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-11
Earnings (Next)04-21
Inst Owners100.87%
Inst Owner Change0.5%
Ins Owners0.49%
Ins Owner Change-2.67%
Market Cap6.44B
Revenue(TTM)8.12B
Net Income(TTM)850.94M
Analysts78.75
Price Target77.23 (17.21%)
Short Float %5.1%
Short Ratio4.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.92%
Min EPS beat(2)-2.85%
Max EPS beat(2)1.01%
EPS beat(4)2
Avg EPS beat(4)0.19%
Min EPS beat(4)-5.59%
Max EPS beat(4)8.2%
EPS beat(8)5
Avg EPS beat(8)1.44%
EPS beat(12)7
Avg EPS beat(12)4.86%
EPS beat(16)11
Avg EPS beat(16)6.37%
Revenue beat(2)1
Avg Revenue beat(2)1.09%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)4.54%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)4.54%
Revenue beat(8)6
Avg Revenue beat(8)1.28%
Revenue beat(12)10
Avg Revenue beat(12)3.22%
Revenue beat(16)12
Avg Revenue beat(16)2.2%
PT rev (1m)0.29%
PT rev (3m)3.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-4.5%
Revenue NY rev (3m)-5.73%
Valuation
Industry RankSector Rank
PE 8.49
Fwd PE 10
P/S 0.77
P/FCF 11.3
P/OCF 10.57
P/B 1.04
P/tB 1.17
EV/EBITDA 6.57
EPS(TTM)7.76
EY11.78%
EPS(NY)6.59
Fwd EY10%
FCF(TTM)5.83
FCFY8.85%
OCF(TTM)6.23
OCFY9.46%
SpS85.73
BVpS63.28
TBVpS56.49
PEG (NY)N/A
PEG (5Y)0.36
Graham Number105.11
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 13.76%
ROCE 14.26%
ROIC 10.88%
ROICexc 11.38%
ROICexgc 12.38%
OM 14.53%
PM (TTM) 10.16%
GM 23.91%
FCFM 6.8%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.98%
ROE(5y)16.31%
ROIC(3y)10.69%
ROIC(5y)11.14%
ROICexc(3y)11.72%
ROICexc(5y)12.31%
ROICexgc(3y)13.29%
ROICexgc(5y)14.07%
ROCE(3y)14.01%
ROCE(5y)14.6%
ROICexgc growth 3Y-14.33%
ROICexgc growth 5Y13.76%
ROICexc growth 3Y-12.76%
ROICexc growth 5Y14.64%
OM growth 3Y-6.84%
OM growth 5Y13.63%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
F-Score7
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.84
Debt/EBITDA 1.74
Cap/Depr 100.08%
Cap/Sales 0.47%
Interest Coverage 250
Cash Conversion 48.49%
Profit Quality 66.97%
Current Ratio 6.43
Quick Ratio 0.58
Altman-Z 3.88
F-Score7
WACC8.89%
ROIC/WACC1.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
EPS Next Y-15.13%
EPS Next 2Y2.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%
Revenue Next Year-14.69%
Revenue Next 2Y-3.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.7%
EBIT growth 3Y-7.23%
EBIT growth 5Y20.21%
EBIT Next Year-12.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3775.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2123.3%
OCF growth 3YN/A
OCF growth 5YN/A

TAYLOR MORRISON HOME CORP / TMHC FAQ

What is the ChartMill fundamental rating of TAYLOR MORRISON HOME CORP (TMHC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMHC.


What is the valuation status for TMHC stock?

ChartMill assigns a valuation rating of 7 / 10 to TAYLOR MORRISON HOME CORP (TMHC). This can be considered as Undervalued.


How profitable is TAYLOR MORRISON HOME CORP (TMHC) stock?

TAYLOR MORRISON HOME CORP (TMHC) has a profitability rating of 8 / 10.


What is the earnings growth outlook for TAYLOR MORRISON HOME CORP?

The Earnings per Share (EPS) of TAYLOR MORRISON HOME CORP (TMHC) is expected to decline by -15.13% in the next year.